FB 003 - Federation Bio
Alternative Names: FB-003Latest Information Update: 02 Aug 2023
At a glance
- Originator Federation Bio
- Class Anti-inflammatories; Bacteria
- Mechanism of Action Microbiome modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Inflammatory bowel diseases
Most Recent Events
- 10 Jul 2023 Pharmacodynamics data from a preclinical trials in Inflammatory bowel disease released by Federation Bio prior July 2023 Federation Bio pipeline, July 2023)
- 03 Jul 2023 Preclinical trials in Inflammatory Bowel Syndrome in USA (PO) (Federation Bio pipeline, July 2023)